Cancer Biology and the Nuclear Envelope : Recent Advances May Elucidate Past Paradoxes / edited by Eric C. Schirmer, Jose I. de las Heras
Contributor(s): Schirmer, Eric C., editor literario
| Heras, Jose I. de las, editor literario
Material type:
E-bookSeries: Publisher: New York : Springer International Publishing, 2014Description: 1 recurso en línea (XIII, 611 p.) 98 il., 84 il. col..ISBN: 9781489980328.Subject: Cáncer -- Investigación
Summary: "Nuclear envelope (NE) defects have been linked to cancer biology since the mid-1800s, but it was not until the last few years that we have begun to understand these historical links and to realize that there are myriad ways that the NE impacts on tumorigenesis. The NEÂ{u0A73} a complex double membrane system that encloses the genome while providing structural support through the intermediate filament lamin polymer and regulating protein/ mRNA trafficking and signaling between the nucleus and cytoplasm via the nuclear pore complexes (NPCs). These functions already provide some mechanisms for NE influences on cancer biology, but work in the past few years has elucidated many others. Lamins and many recently identified NE transmembrane proteins (NETs) have been now shown to function in DNA repair, regulation of cell cycle and signaling, apoptosis, cell migration in metastasis, and nuclear architecture and morphology. This volume presents a comprehensive overview of the wide range of functions recently identified for NE proteins and their relevance in cancer biology, providing molecular mechanisms and evidence of their value as prognostic and diagnostic markers, and suggesting new avenues for the treatment of cancer. Indeed some of these recent links are already yielding promising therapies, such as the current clinical trial of selective inhibitors of the nuclear export factor exportin in certain types of leukemia, melanoma and kidney cancer"
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC267 .S357 2014 EB (Browse shelf(Opens below)) | .i11546463 | Acceso electrónico | eBOOK .i11546463 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RC267 .D53 2013 EB DNA Repair of Cancer Stem Cells | RC267 .F766 2016 EB Frontiers in Cancer Research : Evolutionary Foundations, Revolutionary Directions | RC267 .J35 2014 EB Applications of Biotechnology in Oncology | RC267 .S357 2014 EB Cancer Biology and the Nuclear Envelope : Recent Advances May Elucidate Past Paradoxes | RC267 .V47 2013 EB Vesicle trafficking in cancer | RC268 2014 EB Fundamentals of Cancer Prevention | RC268 2018 EB Bioactive Components, Diet and Medical Treatment in Cancer Prevention |
"Nuclear envelope (NE) defects have been linked to cancer biology since the mid-1800s, but it was not until the last few years that we have begun to understand these historical links and to realize that there are myriad ways that the NE impacts on tumorigenesis. The NEÂ{u0A73} a complex double membrane system that encloses the genome while providing structural support through the intermediate filament lamin polymer and regulating protein/ mRNA trafficking and signaling between the nucleus and cytoplasm via the nuclear pore complexes (NPCs). These functions already provide some mechanisms for NE influences on cancer biology, but work in the past few years has elucidated many others. Lamins and many recently identified NE transmembrane proteins (NETs) have been now shown to function in DNA repair, regulation of cell cycle and signaling, apoptosis, cell migration in metastasis, and nuclear architecture and morphology. This volume presents a comprehensive overview of the wide range of functions recently identified for NE proteins and their relevance in cancer biology, providing molecular mechanisms and evidence of their value as prognostic and diagnostic markers, and suggesting new avenues for the treatment of cancer. Indeed some of these recent links are already yielding promising therapies, such as the current clinical trial of selective inhibitors of the nuclear export factor exportin in certain types of leukemia, melanoma and kidney cancer"
There are no comments on this title.